Search at Vanderbilt-Ingram Cancer Center

1262 results found

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Relevance: 1

Open-Label, Single-Arm Phase 2 Study of Nogapendekin Alfa Inbakicept, PD-L1 T-haNK, Bevacizumab and Randomized Phase 2b Study of Nogapendekin Alfa Inbakicept, Bevacizumab, and Tumor Treatment Fields with or without PD-L1 T-haNK in Participants with Recurrent or Progressive Glioblastoma

Relevance: 1

A Phase 1/2 Study of M3814 (Peposertib) in Combination With Hypofractionated Radiotherapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma

Relevance: 1

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-250 in Participants with Relapsed or Refractory Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Relevance: 1

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

Relevance: 1

Molecular Analysis for Combination Therapy Choice (ComboMATCH)

Relevance: 1

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Relevance: 1

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC

Relevance: 1

Promoting Self-Management in Head and Neck Cancer Survivors with Lymphedema and Fibrosis [PROMISE Trial]

Relevance: 1

A Phase 1, Open-Label Dose Escalation and Expansion Study of STX-0712 in Patients with Advanced Hematologic Malignancies

Relevance: 1